The store will not work correctly when cookies are disabled.
1-(4-(bis(4-chlorophenyl)methyl)piperazin-1-yl)prop-2-yn-1-one
ID: ALA4779501
PubChem CID: 162663256
Max Phase: Preclinical
Molecular Formula: C20H18Cl2N2O
Molecular Weight: 373.28
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: C#CC(=O)N1CCN(C(c2ccc(Cl)cc2)c2ccc(Cl)cc2)CC1
Standard InChI: InChI=1S/C20H18Cl2N2O/c1-2-19(25)23-11-13-24(14-12-23)20(15-3-7-17(21)8-4-15)16-5-9-18(22)10-6-16/h1,3-10,20H,11-14H2
Standard InChI Key: LGFAIWUEBNWVDP-UHFFFAOYSA-N
Molfile:
RDKit 2D
25 27 0 0 0 0 0 0 0 0999 V2000
29.1371 -15.3940 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.7264 -14.6786 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.7264 -16.1095 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.1389 -13.9655 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.7289 -13.2505 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.9026 -13.2500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.4879 -13.9705 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.9044 -14.6826 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.9018 -16.1067 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.4871 -16.8213 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.9020 -17.5377 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.7317 -17.5351 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.1385 -16.8199 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.4868 -12.5351 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
27.4881 -18.2496 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
29.9626 -15.3940 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
30.3774 -16.1095 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.3774 -14.6786 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.2029 -14.6786 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.6135 -15.3940 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
32.4390 -15.3940 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.2029 -16.1095 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.8539 -14.6786 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
32.8539 -16.1095 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.2664 -16.8238 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
1 3 1 0
2 4 2 0
4 5 1 0
5 6 2 0
6 7 1 0
7 8 2 0
8 2 1 0
3 9 2 0
9 10 1 0
10 11 2 0
11 12 1 0
12 13 2 0
13 3 1 0
6 14 1 0
11 15 1 0
1 16 1 0
16 17 1 0
16 18 1 0
18 19 1 0
17 22 1 0
19 20 1 0
20 21 1 0
20 22 1 0
21 23 2 0
21 24 1 0
24 25 3 0
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 373.28 | Molecular Weight (Monoisotopic): 372.0796 | AlogP: 3.86 | #Rotatable Bonds: 3 |
Polar Surface Area: 23.55 | Molecular Species: NEUTRAL | HBA: 2 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 3 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 5.38 | CX LogP: 4.39 | CX LogD: 4.38 |
Aromatic Rings: 2 | Heavy Atoms: 25 | QED Weighted: 0.76 | Np Likeness Score: -0.97 |
References
1. Eaton JK,Furst L,Cai LL,Viswanathan VS,Schreiber SL. (2020) Structure-activity relationships of GPX4 inhibitor warheads., 30 (23.0): [PMID:32920142] [10.1016/j.bmcl.2020.127538] |
2. Karaj E, Sindi SH, Kuganesan N, Perera L, Taylor W, Tillekeratne LMV.. (2022) Tunable Cysteine-Targeting Electrophilic Heteroaromatic Warheads Induce Ferroptosis., 65 (17.0): [PMID:35984756] [10.1021/acs.jmedchem.2c00909] |